Press Release – New York, NY – July 14, 2025 – Sichenzia Ross Ference Carmel LLP announced that it represented ThinkEquity as the sole placement agent for the recently priced $5.7 million offering of CEL-SCI Corporation (NYSE American: CVM), a clinical stage cancer immunotherapy company.
The transaction was a best-efforts offering of common stock, priced at-the-market under NYSE American rules.
The ThinkEquity team was led by Eric Lord and Brian Carstens.
The SRFC team was led by partners Ross Carmel and Avital Perlman, with associate Soumya Cheedi.
